Stable Istotope Labelled Ramucirumab Biosimilar – Anti-VEGFR-2 mAb – Research Grade
|Product name||Stable Istotope Labelled Ramucirumab Biosimilar - Anti-VEGFR-2 mAb - Research Grade|
|Expression system||Mammalian cells|
|Delivery condition||Blue Ice|
|Delivery Time||3-5 days if in stock; 5-8 weeks if production needed|
|Storage condition||4°C for short term; -20°C for long term|
|Note||For research use only. Not suitable for clinical or therapeutic use.|
|Labelling||Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%|
General information about Ramucirumab
Ramucirumab is a monoclonal antibody. Monoclonal antibodies are created in a lab to attach to the targets found on specific types of cancer cells. The antibody “calls” the immune system to attack the cell it is attached to, resulting in the immune system killing the cell. These antibodies can work in different ways, including stimulating the immune system to kill the cell, blocking cell growth or other functions necessary for cell growth. Ramucirumab inhibits the activity of vascular endothelial growth factor (VEGF). VEGF is responsible for angiogenesis, or the development of new blood vessels by and for the tumor (or any tissue), so blocking VEGF’s activity prevents the growth of new blood vessels, essentially cutting off the tumor’s source of nutrients. This product is for research use only.
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.